跳至主要内容
临床试验/NCT05176392
NCT05176392招募中不适用

Combined Nonpharmacological Therapies for MTBI-Related Headaches

Veterans Medical Research Foundation2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
240
试验地点
2
主要终点
Debilitating Headache Interference

研究概览

简要总结

This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.

详细描述

This study will be enrolling a total of 240 veterans or active military over a 4 year period at the VA San Diego Healthcare System (VASDHS). Participants will be randomized into one of four groups:

Group A: active rTMS with telehealth headache management therapy Group B: active rTMS with telehealth headache education control Group C: sham rTMS with telehealth headache management therapy Group D: sham rTMS with telehealth headache education control

Individual participation will consist of 19 visits to the VASDHS and 11 telehealth sessions over the course of 6-7 months. The in person visits will be divided into the following phases:

  1. PRE-TREATMENT ASSESSMENTS PHASE (weeks 1-2) which consists of Visit 1 (Screening Visit) and Visit 2 (Baseline Assessments with MRI scan);
  2. INDUCTION TREATMENT PHASE (weeks 3-4) consists of Visits 3-12 (10 weekday neuronavigation guided rTMS sessions at >24 and <72 hours apart); and
  3. POST-TREATMENT ASSESSMENTS AND MAINTENANCE TREATMENT PHASE (weeks 5-24) consists of 4 initial biweekly post-induction treatment assessments and maintenance treatments (Visits 13-16)) and two additional monthly post-induction assessments and maintenance treatments (Visits 17-18) and one final study visit (Visit 19).

Eight weekly telehealth therapy/education sessions will be conducted from week 3 to 10 with additional three bolster sessions at 4 weeks apart. During the baseline and follow up visits, assessments will be conducted to evaluate headaches, neurobehavioral symptoms, depressive symptoms, post-concussion symptoms, and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The participant, study coordinators and the investigators will be blinded to the rTMS treatment. The participant will be blinded to the therapy group (headache management or headache education).

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Mild Traumatic Brain Injury (mTBI)
  • Chronic headaches > 3 months after injury
  • No prior TMS treatment
  • Persistent Headaches with an intensity > 30 / 100
  • No history of daily headache prior to mTBI

排除标准

  • Pacemaker or any metal in body that would prevent MRI
  • History of dementia or major psychiatric disease, such as bipolar disorder or schizophrenia
  • Presence of any other chronic neuropathic pain states
  • History of seizure
  • Pending litigation
  • Can't understand English
  • History of chronic headache like migraine prior to mTBI
  • Evidence in chart of exacerbation of depressive/anxiety symptoms, active substance dependence, suicidal intent or attempt within previous month

结局指标

主要结局

Debilitating Headache Interference

时间窗: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit

Assesses the interference of debilitating headaches for activities of daily living, from 0, being no interference, to 10, being worst possible interference.

Intensity of Debilitating Headaches

时间窗: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit

Assesses the intensity of debilitating headaches, from a scale of 0, being no pain, to 10, being worst possible pain.

Persistent Headache Frequency

时间窗: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit

Assesses the frequency per week of persistent headaches

Debilitating Headache Frequency

时间窗: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit

Assesses the frequency per week of debilitating headaches

Intensity of Persistent Headaches

时间窗: Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit

Assesses the intensity of persistent headaches, from a scale of 0, being no pain, to 10, being worst possible pain.

次要结局

  • Hamilton Rating Scale for Depression(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)
  • Neurobehavioral Symptom Inventory(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)
  • Rivermead Post-Concussion Symptoms Questionnaire(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)
  • Headache Impact Test(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)
  • Short-Form NEURO-QoL(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)
  • Short Form Health Survey-36(Change from baseline to 2-, 4-, 6-, 8-, 12-, 16-, and 20-weeks follow up visit)

研究者

发起方
Veterans Medical Research Foundation
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验